Viewing Study NCT07215468

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:28 PM
Ignite Modification Date: 2026-05-12 @ 6:20 AM
Study NCT ID: NCT07215468
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2025-10-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: HIV-1 Virologic Suppression With TMB-365 and TMB-380 Antibodies Study
Sponsor: TaiMed Biologics Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV -1 Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HIV-1 maintenance treatment View
None HIV switch therapy View
None Broadly neutralizing antibody (bNAb) View
None HIV post-attachment inhibitor View
None monoclonal antibody (mAb) View